I2O Therapeutics Is A Biotechnology Company Based In Cambridgemassachusettsfounded In 2019The Company Specializes In Developing Innovative Drug Delivery Platforms Using Ionic Liquidsparticularly Aimed At Transforming Injectable Biologics Into Oral Formsthis Technology Enhances Patient Accessibility And Convenience In Treatment The Company Focuses On Several Key Areasincluding The Oral Administration Of Peptides And Proteinsproprietary Peptides For Therapies Targeting Cardiometabolic Diseases Like Type 2 Diabetes And Obesityand A Sustained Delivery System Known As Medicia Cwhich Allows For Biannual Dosing Of Chronic Medicationsi2O Therapeutics Has A Pipeline That Includes Long Acting Peptide And Hormone Analogs Designed To Address Various Metabolic Conditions I2O Therapeutics Collaborates With Major Pharmaceutical Companiesincluding Janssen And Sanofito Explore The Oral Delivery Of Macromolecules And Nanobody Based Medicinesthese Partnerships Reflect The Company S Dedication To Advancing Drug Delivery Solutions In The Healthcare Industry
